Joe Keegan Joseph D. Keegan

Biography

Dr. Keegan has more than 25 years of experience managing life science tools businesses. Since joining ForteBio, Inc. in 2007 he led the Series C financing which raised $25M and established product development and sales strategies that have resulted in compounded annual revenue growth of 45%. During his 9-year tenure at Molecular Devices Corporation, Dr. Keegan grew the company's revenues from $30 million to $190 million through internal growth and acquisitions. In early 2007, he oversaw its acquisition by MDS for $615 million. Dr. Keegan joined MDC from Becton Dickinson and Company where he served as President of Worldwide Tissue Culture and Vice President, General Manager of Worldwide Flow Cytometry. Prior to Becton Dickinson, Dr. Keegan was Vice President of the Microscopy and Scientific Instruments Division of Leica, Inc. He currently serves on the Board of Directors of ALSSA as Chairman, Seahorse Bioscience Inc., Stereotaxis, Inc. (Nasdaq: STXS) and Response Biomedical Corp (RBM:Toronto). Dr. Keegan holds a Ph.D. in Physical Chemistry from Stanford University.

Research Interest

Business, Management, Finance, Pharmaceuticals, Life science, Pharmacology